Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
15.05
+1.67 (12.48%)
At close: Dec 5, 2025, 4:00 PM EST
15.16
+0.11 (0.73%)
After-hours: Dec 5, 2025, 7:52 PM EST
Kazia Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Kazia Therapeutics stock have an average target of 16, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 6.31% from the current stock price of 15.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 2, 2025.
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +32.89% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $13 | Strong Buy | Maintains | $2 → $13 | -13.62% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | -0.33% | Jun 11, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | -0.33% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +564.45% | Jul 12, 2024 |
Financial Forecast
Revenue This Year
51.00K
from 1.83M
Decreased by -97.21%
Revenue Next Year
31.11K
from 51.00K
Decreased by -39.00%
EPS This Year
-1.20
from -18.89
EPS Next Year
-0.57
from -1.20
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 105,000 | 64,050 | |||
| Avg | 51,000 | 31,110 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -94.3% | 25.6% | |||
| Avg | -97.2% | -39.0% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.05 | - | |||
| Avg | -1.20 | -0.57 | |||
| Low | -1.32 | -1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.